BA
INSM icon

BlackRock Advisors’s Insmed INSM Stock Holding History

BlackRock Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$430K Sell
32,506
-6,484
-17% -$88.5K ﹤0.01% 2281
2016
Q3 		$566K Buy
38,990
+9,058
+30% +$113K ﹤0.01% 2111
2016
Q2 		$295K Sell
29,932
-7,522
-20% -$87.8K ﹤0.01% 2412
2016
Q1 		$475K Sell
37,454
-11,849
-24% -$156K ﹤0.01% 2095
2015
Q4 		$895K Sell
49,303
-26,026
-35% -$459K ﹤0.01% 1767
2015
Q3 		$1.4M Buy
75,329
+4,573
+6% +$114K ﹤0.01% 1503
2015
Q2 		$1.73M Buy
70,756
+40,311
+132% +$915K ﹤0.01% 1338
2015
Q1 		$633K Buy
30,445
+4,594
+18% +$80.9K ﹤0.01% 1895
2014
Q4 		$400K Sell
25,851
-38,698
-60% -$549K ﹤0.01% 2158
2014
Q3 		$842K Sell
64,549
-8,272
-11% -$125K ﹤0.01% 1548
2014
Q2 		$1.46M Buy
72,821
+48,173
+195% +$713K ﹤0.01% 1286
2014
Q1 		$469K Buy
24,648
+1,813
+8% +$34.5K ﹤0.01% 2090
2013
Q4 		$388K Buy
22,835
+1,626
+8% +$24.9K ﹤0.01% 2230
2013
Q3 		$331K Buy
21,209
+3,465
+20% +$44K ﹤0.01% 2210
2013
Q2 		$212K Buy
+17,744
New +$181K ﹤0.01% 2436

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors's INSM Position: Q4 2016 in Review

BlackRock Advisors reduced its Insmed (INSM) stake by 17% in Q4 2016, selling an estimated $88.5K and leaving 32,506 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #2281.

BlackRock Advisors first reported a position in INSM in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.73M in Q2 2015. 101 funds tracked by Wall St. Rank hold INSM as of Q4 2016.

  • BlackRock Advisors held 32,506 shares of Insmed worth $430K as of Q4 2016.
  • BlackRock Advisors sold 6,484 Insmed shares in Q4 2016, an estimated $88.5K.
  • Insmed made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2281 holding.
  • BlackRock Advisors first reported a position in Insmed in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Insmed position peaked at $1.73M in Q2 2015.
  • 101 funds tracked by Wall St. Rank held Insmed as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.